Ocular complications following intravitreal Bevacizumab (Ava

Abstract

To assess the rate of ocular complications in patients following intravitre albevacizumab (Avastine) injection for patients with proliferative Diabetic Retinopathy. The study was conducted IBSAR center in Al-NAJAF, IRAQ on 2014, 100 patients participated in the study, their age ranging from 50 years old to 63 years old and followed up for 6 months for observation of the complications. The results were; ten patients have subconjunctival hemorrhage, two patients have post-operative endophthalmitis, three patients have slightly increase in their IOP post operatively, five patients complain of post-operative ocular pain, Sterile uveitis occurs in 1 patient, No retinal detachment occurs, No vitreous hemorrhage occurs. Intravitreal (Avastin) injectionis generally safe with minimal risks, if we take good attention regarding sterilization, technique & surgical procedure.